Mark For: GBT PILLAR™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88607386 |
Mark Literal Elements | GBT PILLAR |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | TMO LAW OFFICE 116 2020-02-07 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Harold Milstein |
Attorney Docket Number | 57LZ-263366 |
Law Office Assigned | M70 |
Employee Name | EUBANK, REBECCA A |
2019-09-06 | Application Filed |
2019-12-17 | Location: TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED |
2019-12-17 | Status: Live/Pending |
2019-12-17 | Transaction Date |
2020-01-30 | Status: Applicant's response to a non-final Office action has been entered. The application is being returned to the examining attorney |
2020-02-07 | Location: TMO LAW OFFICE 116 |
Party: | Global Blood Therapeutics, Inc. |
Address | 171 Oyster Point Blvd., Suite 300 South San Francisco, CALIFORNIA UNITED STATES 94080 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | IMAGE/JPEG | 2019-09-06 |
TEAS RF New Application | MULTI | 2019-09-06 |
XSearch Search Summary | XML | 2019-12-09 |
Offc Action Outgoing | MULTI | 2019-12-17 |
Response to Office Action | APPLICATION/XML | 2020-01-29 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2020-01-31 |
IC 035. US 100 101 102. G & S: Pharmacy referral services provided via a global computer network; specialized retail pharmacy referral services for patients with particular medical conditions; promoting public awareness of the interests of sickle cell disease patients
IC 036. US 100 101 102. G & S: Prescription drug claims administration services, namely, healthcare insurance verification in the nature of insurance claim verification and payer reimbursement assessment and verification for prescription drugs; providing patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with information on available insurance benefits regarding pharmaceuticals, medical coverage, reimbursement options and financial support for that therapy
IC 044. US 100 101. G & S: Providing medical information regarding sickle cell disease, therapeutic properties of pharmaceuticals, and medical treatment for sickle cell disease via a website and call center; providing health information regarding sickle cell disease, therapeutic properties of pharmaceuticals, and medical treatment for sickle cell disease; providing a website featuring information in the medical and health fields in the nature of information regarding sickle cell disease, therapeutic properties of pharmaceuticals, and medical treatment for sickle cell disease; medical services, namely, assisting in the monitoring, adherence and compliance of patients to medical treatments
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 36 |
U.S. Codes: | 100,101,102 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0351 | Pharmacy referral services provided via a global computer network; specialized retail pharmacy referral services for patients with particular medical conditions; promoting public awareness of the interests of sickle cell disease patients |
Description | Date | Proceeding Number |
---|---|---|
ASSIGNED TO EXAMINER | 2020-02-07 | 74671 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-01-30 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-01-29 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-01-29 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-12-17 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-12-17 | 93927 |
NON-FINAL ACTION E-MAILED | 2019-12-17 | 6325 |
ASSIGNED TO EXAMINER | 2019-12-09 | 93927 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-09-18 | |
NEW APPLICATION ENTERED IN TRAM | 2019-09-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.